FDA announces funding for MUMS drugs

美国FDA宣布拨款支持少使用和少数类动物兽药开发

冯丽芳 译

The US Food and Drug Administration (FDA) has announced a funding program to support the development of animal drugs for use in minor species, or for minor uses in major species.

美国FDA宣布支持大动物少使用和少数类动物兽药开发拨款计划。

The program follows the Minor Use & Minor Species Animal Health Act of 2004, known as the MUMS act, and will provide a total amount of $750,000 in funding for the fiscal year ending September 30, 2009.

该计划响应2004年《少使用和少数类动物保健法》，通常所说的MUMS法，并将提供总计750，000美元资金的支持，于2009年9月30日发放结束。

According to FDA’s center for Veterinary Medicine, MUMS grants have the purpose of “defraying the costs of qualified safety and effectiveness testing expenses incurred in connection with the development of designated new animal drugs.” Grants for total costs will be available for up to $50,000 per year for up to two years for studies of unusual complexity, duration or size. A third year of funding may be available for long-term toxicology studies, announced the FDA.

根据FDA兽药中心，MUMS赠款的目的是“支付与指定的新兽药开发相关的合格的安全性和有效性测试费用。”资助的总成本将达到每年5万美元，支助两年研究不寻常的复合物，及其持续时间或大小。第三年的资金可用于长期毒理学研究。

Applications will be accepted until July 1, and they are available in the website www.grants.gov. Major species are horses, dogs, cats, cattle, pigs, turkeys and chickens.

申请将于7月1日之前受理，他们都可以在网站www.grants.gov上看到 。主要品种有马，狗，猫，牛，猪，火鸡和鸡。